本頁面由Tiger Trade Technology Pte. Ltd.提供服務

再鼎醫藥

18.00
+0.49002.80%
盤後18.000.00000.00%17:58 EDT
成交量:69.19萬
成交額:1,246.00萬
市值:19.98億
市盈率:-11.23
高:18.46
開:18.07
低:17.85
收:17.51
52周最高:44.34
52周最低:15.96
股本:1.11億
流通股本:1.09億
量比:0.65
換手率:0.63%
股息:- -
股息率:- -
每股收益(TTM):-1.6026
每股收益(LYR):-1.6026
淨資產收益率:-22.56%
總資產收益率:-12.16%
市淨率:2.79
市盈率(LYR):-11.23

資料載入中...

2025/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/03

重要事件披露

Form 8-K - Current report
2024/12/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities